Management of rectal cancer and liver metastatic disease: which comes first?

Georgios Tsoulfas, Manousos-Georgios Pramateftakis, Georgios Tsoulfas, Manousos-Georgios Pramateftakis

Abstract

In the last few decades there have been significant changes in the approach to rectal cancer management. A multimodality approach and advanced surgical techniques have led to an expansion of the treatment of metastatic disease, with improved survival. Hepatic metastases are present at one point or another in about 50% of patients with colorectal cancer, with surgical resection being the only chance for cure. As the use of multimodality treatment has allowed the tackling of more complicated cases, one of the main questions that remain unanswered is the management of patients with synchronous rectal cancer and hepatic metastatic lesions. The question is one of priority, with all possible options being explored. Specifically, these include the simultaneous rectal cancer and hepatic metastases resection, the rectal cancer followed by chemotherapy and then by the liver resection, and finally the "liver-first" option. This paper will review the three treatment options and attempt to dissect the indications for each. In addition, the role of laparoscopy in the synchronous resection of rectal cancer and hepatic metastases will be reviewed in order to identify future trends.

References

    1. Jemal A, Murray T, Ward E, et al. Cancer statistics, 2005. Ca-A Cancer Journal for Clinicians. 2005;55(1):10–30.
    1. Steele G, Ravikumar TS. Resection of hepatic metastases from colorectal cancer: biologic perspectives. Annals of Surgery. 1989;210(2):127–138.
    1. Blumgart LH, Allison DJ. Resection and embolization in the management of secondary hepatic tumors. World Journal of Surgery. 1982;6(1):32–45.
    1. Altendorf-Hofmann A, Scheele J. A critical review of the major indicators of prognosis after resection of hepatic metastases from colorectal carcinoma. Surgical Oncology Clinics of North America. 2003;12(1):165–192.
    1. Fong Y, Fortner J, Sun RL, Brennan MF, Blumgart LH. Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases. Annals of Surgery. 1999;230(3):309–321.
    1. André T, Boni C, Mounedji-Boudiaf L, et al. Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer. The New England Journal of Medicine. 2004;350(23):2343–2351.
    1. Cunningham D, Humblet Y, Siena S, et al. Cetuximab monotherapy and cetuximab plus irinotecan in irinotecan- refractory metastatic colorectal cancer. The New England Journal of Medicine. 2004;351(4):337–345.
    1. Hurwitz H, Fehrenbacher L, Novotny W, et al. Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer. The New England Journal of Medicine. 2004;350(23):2335–2342.
    1. Tournigand C, André T, Achille E, et al. FOLFIRI followed by FOLFOX6 or the reverse sequence in advanced colorectal cancer: a randomized GERCOR study. Journal of Clinical Oncology. 2004;22(2):229–237.
    1. McCarter MD, Fong Y. Metastatic liver tumors. Seminars in Surgical Oncology. 2000;19:177–188.
    1. Bismuth H, Adam R, Lévi F, et al. Resection of nonresectable liver metastases from colorectal cancer after neoadjuvant chemotherapy. Annals of Surgery. 1996;224(4):509–522.
    1. Abdalla EK, Vauthey JN, Ellis LM, et al. Recurrence and outcomes following hepatic resection, radiofrequency ablation, and combined resection/ablation for colorectal liver metastases. Annals of Surgery. 2004;239(6):818–827.
    1. Scheele J, Stangl R, Altendorf-Hofmann A. Hepatic metastases from colorectal carcinoma: impact of surgical resection on the natural history. British Journal of Surgery. 1990;77(11):1241–1246.
    1. Choti MA, Sitzmann JV, Tiburi MF, et al. Trends in long-term survival following liver resection for hepatic colorectal metastases. Annals of Surgery. 2002;235(6):759–766.
    1. Hughes KS, Rosenstein RB, Songhorabodi S, et al. Resection of the liver for colorectal carcinoma metastases. A multi-institutional study of long-term survivors. Diseases of the Colon and Rectum. 1988;31(1):1–4.
    1. Adson MA, van Heerden JA, Adson MH, Wagner JS, Ilstrup DM. Resection of hepatic metastases from colorectal cancer. Archives of Surgery. 1984;119(6):647–651.
    1. Parikh AA, Gentner B, Wu TT, Curley SA, Ellis LM, Vauthey JN. Perioperative complications in patients undergoing major liver resection with or without neoadjuvant chemotherapy. Journal of Gastrointestinal Surgery. 2003;7(8):1082–1088.
    1. Folprecht G, Grothey A, Alberts S, Raab HR, Köhne CH. Neoadjuvant treatment of unresectable colorectal liver metastases: correlation between tumour response and resection rates. Annals of Oncology. 2005;16(8):1311–1319.
    1. Allen PJ, Kemeny N, Jarnagin W, et al. Importance of response to neoadjuvant chemotherapy in patients undergoing resection of synchronous colorectal liver metastases. Journal of Gastrointestinal Surgery. 2003;7(1):109–117.
    1. Karoui M, Penna C, Amin-Hashem M, et al. Influence of preoperative chemotherapy on the risk of major hepatectomy for colorectal liver metastases. Annals of Surgery. 2006;243(1):1–7.
    1. Nordlinger B, Benoist S. Benefits and risks of neoadjuvant therapy for liver metastases. Journal of Clinical Oncology. 2006;24(31):4954–4955.
    1. van Vledder MG, de Jong MC, Pawlik TM, Schulick RD, Diaz LA, Choti MA. Disappearing colorectal liver metastases after chemotherapy: should we be concerned? Journal of Gastrointestinal Surgery. 2010;14(11):1691–1700.
    1. Charnsangavej C, Clary B, Fong Y, Grothey A, Pawlik TM, Choti MA. Selection of patients for resection of hepatic colorectal metastases: expert consensus statement. Annals of Surgical Oncology. 2006;13(10):1261–1268.
    1. Lambert LA, Colacchio TA, Barth RJ. Interval hepatic resection of colorectal metastases improves patient selection. Archives of Surgery. 2000;135(4):473–480.
    1. Bismuth H, Castaing D, Traynor O. Surgery for synchronous hepatic metastases of colorectal cancer. Scandinavian Journal of Gastroenterology, Supplement. 1988;23(149, supplement):144–149.
    1. Scheele J. Hepatectomy for liver metastases. British Journal of Surgery. 1993;80(3):274–276.
    1. Capussotti L, Vigano’ L, Ferrero A, Lo Tesoriere R, Ribero D, Polastri R. Timing of resection of liver metastases synchronous to colorectal tumor: proposal of prognosis-based decisional model. Annals of Surgical Oncology. 2007;14(3):1143–1150.
    1. Lee WS, Kim MJ, Yun SH, et al. Risk factor stratification after simultaneous liver and colorectal resection for synchronous colorectal metastasis. Langenbeck’s Archives of Surgery. 2008;393(1):13–19.
    1. Zhang HZ, Dong SX, Zhou ZX, et al. Simultaneous liver and colorectal resection for synchronous colorectal liver metastases. Zhongua Wai Ke Za Zhi. 2007:45902–45904.
    1. Capussotti L, Ferrero A, Viganò L, Ribero D, Tesoriere RL, Polastri R. Major liver resections synchronous with colorectal surgery. Annals of Surgical Oncology. 2007;14(1):195–201.
    1. Boostrom SY, Vassiliki LT, Nagorney DM, et al. Synchronous rectal and hepatic resection of rectal metastatic disease. Journal of Gastrointestinal Surgery. 2011;15:1583–1588.
    1. Martin R, Paty PB, Fong Y, et al. Simultaneous liver and colorectal resections are safe for synchronous colorectal liver metastasis. Journal of the American College of Surgeons. 2003;197(2):233–242.
    1. Mentha G, Majno P, Terraz S, et al. Treatment strategies for the management of advanced colorectal liver metastases detected synchronously with the primary tumour. European Journal of Surgical Oncology. 2007;33(2):S76–S83.
    1. Adam R. Colorectal cancer with synchronous liver metastases. British Journal of Surgery. 2007;94(2):129–131.
    1. Punt CJA. New options and old dilemmas in the treatment of patients with advanced colorectal cancer. Annals of Oncology. 2004;15(10):1453–1459.
    1. Poultsides GA, Servais EL, Saltz LB, et al. Outcome of primary tumor in patients with synchronous stage IV colorectal cancer receiving combination chemotherapy without surgery as initial treatment. Journal of Clinical Oncology. 2009;27(20):3379–3384.
    1. Benoist S, Pautrat K, Mitry E, Rougier P, Penna C, Nordlinger B. Treatment strategy for patients with colorectal cancer and synchronous irresectable liver metastases. British Journal of Surgery. 2005;92(9):1155–1160.
    1. Mentha G, Majno PE, Andres A, et al. Neoadjuvant chemotherapy and resection of advanced synchronous liver metastases before treatment of the colorectal primary. British Journal of Surgery. 2006;93:872–878.
    1. Brouquet A, Mortenson MM, Vauthey JN, et al. Surgical strategies for synchronous colorectal liver metastases in 156 consecutive patients: classic, combined or reverse strategy? Journal of the American College of Surgeons. 2010;210(6):934–941.
    1. Garden OJ, Rees M, Poston GJ, et al. Guidelines for resection of colorectal cancer liver metastases. Gut. 2006;55(3):iii1–iii8.
    1. Nordlinger B, Guiguet M, Vaillant JC, et al. Surgical resection of colorectal carcinomas metastases to the liver. A prognostic scoring system to improve case selection, based on 1568 patients. Association Francaise de Chirurgie. Cancer. 1996;77:1224–1126.
    1. Weber JC, Bachellier P, Oussoultzoglou E, Jaeck D. Simultaneous resection of colorectal primary tumour and synchronous liver metastases. British Journal of Surgery. 2003;90(8):956–962.
    1. Peeters KCMJ, Tollenaar RAEM, Marijnen CAM, et al. Risk factors for anastomotic failure after total mesorectal excision of rectal cancer. British Journal of Surgery. 2005;92(2):211–216.
    1. Farges O, Belghiti J. Repeat resection of liver metastases. British Journal of Surgery. 2006;93(4):387–388.
    1. Bretagnol F, Hatwell C, Farges O, Alves A, Belghiti J, Panis Y. Benefit of laparoscopy for rectal resection in patients operated simultaneously for synchronous liver metastases: preliminary experience. Surgery. 2008;144(3):436–441.
    1. Casaccia M, Famiglietti F, Andorno E, di Domenico S, Ferrari C, Valente U. Simultaneous laparoscopic anterior resection and left hepatic lobectomy for stage IV rectal cancer. Journal of the Society of Laparoendoscopic Surgeons. 2010;14(3):414–417.
    1. Kim SH, Lim SB, Ha YH, et al. Laparoscopic-assisted combined colon and liver resection for primary colorectal cancer with synchronous liver metastases: initial experience. World Journal of Surgery. 2008;32(12):2701–2706.
    1. Panis Y. Laparoscopy and colorectal cancer. Bulletin de l Academie Nationale de Medecine. 2007;191:375–378.

Source: PubMed

スポンサーと協力者

医学的状態

薬物療法

3
購読する